Medications

Added benefit of lixisenatide is not proven

Lixisenatide (trade name: Lyxumia) has been approved in Germany since February 2013 for the treatment of type 2 diabetes mellitus in combination with oral blood-glucose lowering drugs or basal insulin when these, together ...

Medications

US cracks down on illegal diabetes remedies

(AP)—The Food and Drug Administration is cracking down on more than a dozen U.S. and foreign companies that market illegal treatments for diabetes, ranging from bogus dietary supplements to prescription drugs sold online ...

Alzheimer's disease & dementia

Diabetes drug may protect the brain

(HealthDay)—The diabetes drug metformin may do more than help control blood sugar levels: New research suggests it may also reduce the risk of dementia.

Diabetes

Post-breast cancer, metformin has no effect on mortality

(HealthDay)—For older women with diabetes and breast cancer, there is no association between metformin use and all-cause or breast cancer-specific mortality, according to a study published online April 30 in Diabetes Care.

Obstetrics & gynaecology

Drug combination promotes weight loss in polycystic ovary syndrome

Women with polycystic ovary syndrome, or PCOS, lost significantly more weight when they took two drugs that are traditionally used to treat diabetes, rather than either drug alone, a study from Slovenia demonstrates. The ...

Diabetes

Lixisenatide non-inferior to exenatide for diabetes

(HealthDay)—In adults with type 2 diabetes not adequately controlled with metformin, lixisenatide once daily offers diabetes control similar to that of exenatide twice daily, with some added benefits, according to a study ...

Medications

Added benefit of dapagliflozin is not proven

Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal ...

page 25 from 32